- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1 IPO registration
- 4.3 Form of Specific Common Share Certificate
- 5.1 Opinion of Norton Rose Fulbright Canada LLP
- 10.3 Amended and Restated Executive Employment Agreement, Dated March 1, 2021, Between Eric A. Adams and Inmed Pharmaceuticals Inc
- 10.4 Amended and Restated Executive Employment Agreement, Dated March 1, 2021, Between Eric Hsu and Inmed Pharmaceuticals Inc
- 10.5 Amended and Restated Executive Employment Agreement, Dated March 1, 2021, Between Alexandra Mancini and Inmed Pharmaceuticals Inc
- 10.6 Amended and Restated Executive Employment Agreement, Dated March 1, 2021, Between Michael Woudenberg and Inmed Pharmaceuticals Inc
- 10.7 Amended and Restated Executive Employment Agreement, Dated March 1, 2021, Between Bruce S. Colwill and Inmed Pharmaceuticals Inc
- 23.1 Consent of KPMG LLP, Independent Registered Public Accounting Firm
Exhibit 23.1
KPMG LLP
PO Box 10426 777 Dunsmuir Street
Vancouver BC V7Y 1K3
Canada
Telephone (604) 691-3000
Fax (604) 691-3031
Consent of Independent Registered Public Accounting Firm
The Board of Directors
InMed Pharmaceuticals Inc.:
We consent to the use of our report dated September 8, 2020, with respect to the consolidated financial statements of InMed Pharmaceuticals Inc. included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP |
Chartered Professional Accountants
Vancouver, Canada
July 12, 2021
© 2021 KPMG LLP, an Ontario limited liability partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.